Drugs / Retapamulin
Retapamulin
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Withdrawn | EU (EMA) | Altargo | — | 2019-02-25 | europa.eu ↗ |
| Approved | EU (EMA) | Altargo | — | 2007-05-24 | europa.eu ↗ |
| Approved | US (FDA) | ALTABAX | — | 2007-04-12 | fda.gov ↗ |
Trials 14 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01397461 Comparator | Mar → Dec 2012 | impetigo | Ferrer Internacional S.A. | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01591785 Comparator | Jan → Aug 2012 | atopic eczema, hand dermatosis | Gary Goldenberg | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 18 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Retapamulin | “A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily...” PMID 25396674 ↗ Dec 201413“Retapamulin 1% ointment is to be applied to lesional atopic dermatitis twice-daily in addition to a topical corticosteroid (Locoid lipocream (R))” NCT00871208 ↗ “Altabax (retapamulin)” NCT00903279 ↗ |
| Known as | Altabax | “The authors disclose they will discuss off-label uses of retapamulin 1% (Altabax, Altargo).” PMID 25396674 ↗ Dec 2014 |
| Known as | Altargo | “The authors disclose they will discuss off-label uses of retapamulin 1% (Altabax, Altargo).” PMID 25396674 ↗ Dec 2014 |
| Known as | NSC-759885 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1658 ↗ |
| Known as | Retapamulina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1658 ↗ |
| Known as | Retapamuline | ChEMBL registry synonym — accepted as the source's own label CHEMBL1658 ↗ |
| Known as | SB-275833 | “Topical retapamulin (SB-275833) ointment, 1% (w/w), and placebo ointment” NCT00852540 ↗3“Topical Retapamulin (SB-275833) Ointment, 1%, Twice Daily for Five Days” NCT00555061 ↗ |
| Modality | Small molecule | — CHEMBL1658 ↗ |
| Route | Topical | “Topical SB-275833 ointment, 1%” NCT00133848 ↗ |